Fig. 5From: Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case reportAfter 15 months since the nivolumab discontinuation, the size of the metastatic lymph node was 15 mm × 14 mm (arrow)Back to article page